Evidence map›Paper›PMID 34676319›Full record

ReviewMedical cannabis and cannabinoids2018

Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon?

Magdalena Grill, Carina Hasenoehrl, Martin Storr, Rudolf Schicho

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medical cannabis and cannabinoids, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Antitumor Effects ofBiomolecules · 2023
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Magdalena GrillOtto Loewi Research Center, Pharmacology Section, Medical University of Graz, Graz, Austria.
Carina HasenoehrlOtto Loewi Research Center, Pharmacology Section, Medical University of Graz, Graz, Austria.
Martin StorrDepartment of Medicine 2, Ludwig-Maximilians University, Munich, Germany.
Rudolf SchichoOtto Loewi Research Center, Pharmacology Section, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATLudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past few years, we have witnessed a surge of new reports dealing with the role of cannabinoids, synthetic as well as herbal, in the mechanisms of inflammation and carcinogenesis. However, despite the wealth of in vitro data and anecdotal reports, evidence that cannabinoids could act as beneficial drugs in inflammatory bowel disease (IBD) or in neoplastic development of the human gastrointestinal tract is lacking. Some insight into the effects of medical

Indexed as

Cannabinoid treatmentColorectal cancerInflammatory bowel diseaseIntestinal inflammationTHC

Identifiers

PMID34676319
PMCPMC8489318
OpenAlexW2842806284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.